CEO Insights

How will new entrants drive market change? Insiders at Google and CVS Health explain

Alan Lotvin and David Feinberg share some of the work taking place to use insights gained from the large, growing databases of consumer behavior.

See More

NC Blues’ Patrick Conway in conversation with David Brailer: Transformation from partnerships

In this video interview, Conway and Brailer explore the challenges and market forces driving the move toward this new relationship.

See More

Vinod Khosla on network medicine: The role of primary care physicians will become more important

As AI provides better tools for diagnosis, Khosla believes the role of specialists and primary care doctors will change

See More

Get out of the healthcare bubble to learn new ways to lead

Leaders share the decisions that drove their careers and often pushed them beyond their comfort zone

See More

Eric Schmidt: Until AI’s “unknown errors” can be explained, the systems will remain advisory

AI is making remarkable strides and presenting challenges in the lab.

See More

Adam Boehler: CMS will provide the right incentives for risk-based models to succeed

At the Health Evolution Summit, a preview of the changes that CMS is developing.

See More

To succeed in a risk-based environment, CEOs need to be smart recruiters

Solving today's complex challenges requires new approaches to recruitment.

See More

Coordinating community resources is key to changing social determinants

The social determinants of health—factors like access (or lack of it) to food, shelter and transportation, exposure to environmental contaminants, and risks from domestic or community violence—account for up to 80 percent of a person’s state of health. Increasingly, healthcare providers in accountable care reimbursement arrangements must address them or risk losing money on patients

See More

Social determinants lesson #1: Providers must listen

When Mandy Cohen, MD, Secretary of the North Carolina Department of Health and Human Services, was a young resident, she saw a 24-year-old patient, commercially insured, who was losing weight and even losing her hair. “I did what doctors do—I ordered a lot of lab tests” Cohen said during a main stage discussion at the

See More

Pricing a cure? Experts debate how to ID the true value of 7-figure drugs

Who decides what a drug is worth? This question is central to determining whether and how our healthcare system pays for a new generation of five-, six-, and even seven-figure drugs that promise cures, or at least long-term remissions, for deadly or debilitating diseases. Discussion leaders at the Health Evolution Summit discussion “The Age of

See More

“Drug mortgages” may be the solution to fund million-dollar cures

Buying a six-figure therapy may require individuals to pay over time.

See More

Seema Verma: Without competition there’s no incentive to innovate

Regulatory relief and greater competition are driving changes coming from CMS

See More

Bending the cost curve by making diagnostic advances a priority

Diagnostics is the neglected stepchild of healthcare, but developments in genomics, microbiomics, and metabolomics could change that status, as long as the diagnostics industry can get a fourth “omics”—economics—working in its favor, said Sue Siegel, chief innovation officer and CEO of GE Ventures, and moderator of the the last session at the Health Evolution Summit,

See More

New approaches to diagnostics promise early detection, targeted therapies

How can innovative diagnostic tests prove their value in helping clinicians make treatment decisions? Regulators and payers must decide how they’re going to measure that value, and may have to abandon traditional clinical trial models, said panelists at the Health Evolution Summit panel discussion “Diagnostics Reimagined: Leading an Era of Prevention.” “The single largest opportunity

See More

Partner with – don’t fear – new healthcare players, says Anthem CEO

“We want partners who can integrate," said Anthem CEO Gail Boudreaux,

See More

The state of population health: Stalled or matured?

Is population health stalling? Maybe it’s just slower to implement than originally expected because it’s really hard, according to one provider in the discussion “Provider Connect: Future Bets in Taking Risk” at Health Evolution Summit. “Population health is a bad name,” said Nancy Howell Agee, who has served as president and CEO of Carilion Clinic

See More

The “next generation” of reducing care variability: referrals

Where does the health care industry stand on reducing the variability of care—a key component of improving quality and controlling costs? Even Intermountain Healthcare, Salt Lake City, a decades-long leader in reducing care variation, is “nowhere near done,” says its CEO. Providers need to focus on maintaining quality and reducing cost, before new disruptive competitors take away their patients.

See More

A pilot program improves outcomes by connecting care to housing needs

At a Health Evolution Summit discussion, Diane Holder shares a successful pilot program working with community resources.

See More

Addiction must be fought with evidence-based treatment, not moral judgment

At a Health Evolution Confab discussion, a call to de-stigmatize addiction

See More

The coming data quake: Two tech pioneers will share their vision at Summit 2019

Two of the biggest names in technology will take the main stage at Health Evolution Summit 2019 to address “Tremors from the Coming Data Quake.”

See More

First look: Health Evolution’s latest pilot program

A new vehicle to keep alive the discussion that takes place at the annual Summit.

See More

How will the health care system pay for miracle cures?

A chief irony of the 21st-century U.S. health care financing system is that it struggles to pay for cures. The biopharma pipeline is full of promising gene and stem cell therapies and other innovative approaches that may eventually free us of cancer, diabetes, sickle cell disease, Alzheimer’s disease, blindness, and a host of other deadly

See More

Achieving diversity: Unraveling the unconscious bias

In a video interview, WellCare Health Plans CEO Ken Burdick shares the benefit WellCare achieved through diversity training.

See More

What is the physician’s role in a future driven by AI?

The role of physicians in a world of AI driven healthcare solutions

See More

Progress in addressing the needs of Medicaid and “dual-eligible” patients

A ‘thrive screen’ is helping Boston Medical Center make more informed decisions on where to intervene and invest.

See More